Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Neurology|July 28, 2010
Progression of transthyretin amyloid neuropathy after liver transplantationJuris J Liepnieks, Lucy Q Zhang, Merrill D Benson
Blood|April 11, 2015
Hereditary systemic immunoglobulin light-chain amyloidosisMerrill D Benson, Juris J Liepnieks, Barbara Kluve-Beckerman
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 26, 2006
Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosisJuris J Liepnieks, Donald L Wilson, Merrill D Benson
Arthritis and Rheumatism|July 19, 2002
A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloidBarbara Kluve-Beckerman, John J Manaloor, Juris J Liepnieks
Biochimica Et Biophysica Acta|January 25, 1995
Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1J J Liepnieks, B Kluve-Beckerman, M D Benson
Molecular Immunology|June 1, 1990
Amino acid sequence of a kappa I primary (AL) amyloid protein (AND)J J Liepnieks, F E Dwulet, M D Benson
Proceedings of the National Academy of Sciences of the United States of America|October 10, 1995
Tertiary structure of an amyloid immunoglobulin light chain protein: a proposed model for amyloid fibril formationN Schormann, J R Murrell, J J Liepnieks, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 18, 2009
Biochemical characterisation of amyloid by endomyocardial biopsyMerrill D Benson, Jeffrey Breall, Oscar W Cummings, et al.
QJM : Monthly Journal of the Association of Physicians|October 1, 1996
The molecular basis of renal amyloidosis in Irish-American and Polish-Canadian kindredsT Uemichi, J J Liepnieks, F Alexander, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1996
Accelerated amyloid deposition in mice treated with the aspartic protease inhibitor, pepstatinT Yamada, J Liepnieks, M D Benson, et al.
Pageof 9